The therapeutic efficacy of middle- and low-dose methylprednisolone combined with methotrexate and selenium yeast on Graves ophthalmopathy
10.3760/cma.j.issn.1000-6699.2016.01.007
- VernacularTitle:中小剂量甲泼尼龙联合甲氨蝶呤与硒酵母对 Graves眼病的疗效观察
- Author:
Yi ZHANG
;
Xianfeng ZHANG
;
Hui HAN
;
Jiao HUANG
;
Lizheng MA
;
Chu ZHANG
- Publication Type:Journal Article
- Keywords:
Graves ophthalmopathy;
Methylprednisolone;
Methotrexate;
Selenium
- From:
Chinese Journal of Endocrinology and Metabolism
2016;(1):24-26
- CountryChina
- Language:Chinese
-
Abstract:
[Summary] The efficacy of the combining therapy of methylprednisolone and methotrexate on the Graves ophthalmopathy ( GO) was observed. Whether selenium supplement is beneficial based on this combining therapy scheme was evaluated. The results showed that the combining therapy of methylprednisolone and methotrexate was effective for the patients with moderate-to-severe GO. Selenium supplement did not further improve the remission of GO.
